Panic Disorder Clinical Trial
Official title:
CO2 Inhalation and Risk for Panic Disorder
Objective:
To examine respiratory/physiological and subjective responding as well as genetic
transmission among offspring of parents with a history of or current panic disorder (PD)
diagnosis to determine whether diagnoses/symptoms, endophenotypes, or genetic profiles in
offspring is differentially related to parent PD subtypes (i.e., respiratory and
non-respiratory panic).
Study population:
Approximately 400 offspring of about 200 parents with current or past PD. Approximately 200
offsping/100 parents with PD will be enrolled at NIH/NIMH and the remainder at Virginia
Commonwealth University in Richmond, VA.
Design:
A high-risk family design will be used wherein parents with either a current or past
diagnosis of PD who have an offspring(s) (ages 9 to 20) will be recruited.
<TAB>
Outcome measures:
Outcome measures will include physiological recordings of respiratory, cardiac, and
electrodermal responding during a 10 minute baseline followed by 15 minutes of 5% carbon
dioxide enriched air (CO2). Research participants also will complete parent and child
self-report measures and provide a DNA sample using a saliva protocol. A full listing of
self-reports is provided in the Outcome Measures Section.
Objective:
The objective of this study is to examine respiratory/physiological and subjective responding
as well as genetic transmission among offspring of parents with a history of or current panic
disorder (PD) diagnosis. Our goal is to determine whether diagnoses/symptoms, endophenotypes,
or genetic profiles in offspring is differentially related to parent PD subtypes (i.e.,
respiratory and non-respiratory panic).
Study population:
Approximately 80 offspring between the ages of 9 and 20 years of age who have a parent with a
current or past history of PD will be recruited. Approximately 40 offspring will be enrolled
at NIH/NIMH and the remainder at Virginia Commonwealth University in Richmond, VA.
Design:
Offspring(s) between the ages of 9 to 20 who have a parent with a history of PD will be
recruited. A complete psychiatric history will be obtained on all child participants. Child
participants also will complete questionnaire measures, provide a sample of DNA, and
participate in a carbon dioxide CO(2) lab challenge. The CO(2) lab challenge is the primary
outcome measure.
Outcome measures:
Our primary outcome measures include physiological recordings of respiratory, cardiac, and
electrodermal responding during a 10 minute baseline followed by 15 minutes of 5% carbon
dioxide enriched air (CO(2). Research participants also will complete parent and child
self-report measures and provide a DNA sample using a saliva protocol. A full listing of
self-reports is provided in the Outcome Measures Section.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05868135 -
Effects and Cost-effectiveness of e-Meistring - a Guided Internet-delivered Psychological Treatment
|
||
| Active, not recruiting |
NCT05530642 -
An Augmented Training Program for Preventing Post-Traumatic Stress Injuries Among Diverse Public Safety Personnel
|
N/A | |
| Completed |
NCT02998502 -
The Use of a FDA Cleared, Drug-free, Breathing System for Anxiety and Panic Disorders in Children and Teens
|
N/A | |
| Completed |
NCT01955954 -
Using the Canary Breathing System for Panic Disorder Patients
|
N/A | |
| Completed |
NCT01963806 -
ACT-smart: Smartphone-supplemented iCBT for Social Phobia and/or Panic Disorder
|
N/A | |
| Completed |
NCT01201967 -
A Collaborative Care Program to Improve Treatment of Depression and Anxiety Disorders in Cardiac Patients
|
Phase 4 | |
| Completed |
NCT00711737 -
Study of the Changes in Metabolic Parameters in Patients Treated With Escitalopram for Six Months
|
N/A | |
| Completed |
NCT00605813 -
Special Investigation Of Long Term Use Of Sertraline.
|
||
| Completed |
NCT00525226 -
Evaluating the Effects of Stress in Pregnancy
|
N/A | |
| Completed |
NCT00353470 -
Comparison of Psychotherapy Programs to Treat Panic Disorder
|
Phase 3 | |
| Completed |
NCT00167479 -
A Study of Risperidone Monotherapy in Bipolar Anxiety
|
Phase 4 | |
| Completed |
NCT00540098 -
Paroxetine vs Placebo Combined With Aerobic Exercise or Relaxation in Panic Disorder
|
Phase 4 | |
| Completed |
NCT03233542 -
The Association Between Physical Sensations and Thinking Styles
|
N/A | |
| Recruiting |
NCT05967468 -
Evaluation of Family-Based Behavioral Treatments for Youth With Anxiety and Obsessive-Compulsive Disorder
|
N/A | |
| Completed |
NCT02811458 -
Clinical Trial of Transdiagnostic Cognitive-Behavior Therapy for Anxiety Disorders
|
N/A | |
| Active, not recruiting |
NCT05124639 -
Clinical Trial of a Group Self-management Support Program for Anxiety Disorders
|
N/A | |
| Completed |
NCT04592536 -
A Trial of the Effect of CVL-865 on Panic Symptoms Induced by Carbon Dioxide Inhalation in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT00025974 -
Brain Chemical Receptor Effects in Patients With Panic Disorder and Post-Traumatic Stress Disorder
|
N/A | |
| Recruiting |
NCT02305537 -
Building an Outcomes Assessment Infrastructure to Assess Anxiety Treatment
|
N/A | |
| Terminated |
NCT01680107 -
D-cycloserine Augmented CBT for Panic Disorder
|
Phase 3 |